Related Experiment Videos
Aspartate and glutamate-enriched cardioplegia in left ventricular dysfunction
Ibrahim Uyar1, Denyan Mansuroğlu, Kaan Kirali
1Department of Cardiovascular Surgery, Koşuyolu Heart and Research Hospital, Istanbul, Turkey.
Journal of Cardiac Surgery
|June 30, 2005
Summary
L-aspartate and L-glutamate cardioplegia did not improve left ventricular function after bypass surgery in patients with moderate dysfunction. This study found no significant difference in recovery or myocardial enzyme levels between groups.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardioplegia Research
Background:
- Investigating the impact of L-aspartate and L-glutamate-enriched cardioplegia on cardiac function.
- Focusing on patients with moderate left ventricular dysfunction (LVEF 30-40%) undergoing coronary artery bypass surgery.
Purpose of the Study:
- To evaluate the efficacy of L-aspartate and L-glutamate in improving postoperative left ventricular function.
- Comparing outcomes between a substrate-enriched cardioplegia group and a standard cardioplegia group.
Main Methods:
- Prospective randomized study of 22 patients with moderate left ventricular dysfunction.
- Comparison of isothermic substrate-enriched (L-aspartate and L-glutamate) blood cardioplegia versus standard potassium-based cardioplegia.
- Monitoring of hemodynamic parameters, perfusion time, aortic cross-clamp time, and cardioplegic solution volume.
Main Results:
- No significant differences in intra- or postoperative periods between groups.
- Similar myocardial acidosis and lactate levels despite more severe acidosis in the control group.
- Higher Troponin-T levels observed in the control group, indicating potential myocardial damage.
Conclusions:
- L-aspartate and L-glutamate may support myocardial metabolic functions.
- These amino acids did not demonstrate a significant effect on myocardial functional recovery in this patient cohort.
- Further research may be needed to explore their role in specific cardiac conditions.